Title : The effect of risedronate treatment on serum cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study.

Pub. Date : 2009

PMID : 19301089






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In group 1 (risedronate plus calcium/vitamin D-treated patients), serum levels of RANKL and IL-1beta significantly decreased and the level of osteoprotegerin significantly increased after three and 6 months, but no significant difference was found in TNF-alpha level. Risedronic Acid interleukin 1 beta Homo sapiens
2 In conclusion risedronate could improve osteoporosis by increasing osteoprotegerin and reducing RANKL and IL-1beta. Risedronic Acid interleukin 1 beta Homo sapiens